earnings
confidence high
sentiment negative
materiality 0.85
Q4 net loss $1.1B, EPS $(2.91); FY2024 revenue $3.2B falls 53%; guides 2025 rev $1.5-2.5B
Moderna, Inc.
2024-FY EPS reported
-$9.28
revenue$3,236,000,000
- Q4 revenue $1.0B (-66% YoY); GAAP net loss $1.1B vs net income $217M in Q4 2023.
- FY2024 revenue $3.2B (-53% YoY); GAAP net loss $3.6B; EPS $(9.28).
- FY2024 cost of sales 47% of net product sales, including $238M non-cash charge for manufacturing agreement termination.
- 2025 revenue guided $1.5-2.5B; expects first-half 2025 revenue only ~$0.2B due to seasonality.
- Filed three BLAs: next-gen COVID (PDUFA May 31), RSV for 18-59 (PDUFA June 12), flu/COVID combo.